Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y ▲ |
|---|---|---|---|---|---|---|---|
| Bluebird Bio Inc. | -1.790% | -10.000% | -50.069% | -85.973% | -59.422% | -96.660% | -99.442% |
| Fibrogen Inc. | -2.680% | -9.964% | -27.936% | -67.762% | -64.710% | -97.126% | -99.192% |
| Sage Therapeutics Inc. | -6.040% | 0.647% | -18.692% | -61.915% | -64.200% | -81.688% | -95.289% |
| Nektar Therapeutics | 1.880% | -1.240% | 0.996% | 102.139% | 123.851% | -91.654% | -92.751% |
| Emergent Biosolutions Inc. | -1.320% | -16.779% | -27.905% | 36.078% | 199.641% | -87.446% | -86.848% |
| Novocure Ltd | 0.820% | -15.070% | -20.574% | -26.891% | 5.604% | -87.071% | -80.289% |
| Xencor Inc. | -1.940% | 1.333% | -13.143% | -25.490% | -20.419% | -46.137% | -53.503% |
| Iovance Biotherapeutics Inc. | -3.580% | -7.196% | 32.689% | 65.954% | 21.235% | -54.115% | -51.266% |
| Ironwood Pharmaceuticals | -0.890% | 3.738% | -25.378% | -48.070% | -56.471% | -58.505% | -47.080% |
| Acadia Pharmaceuticals | 1.500% | 4.885% | -13.841% | -40.740% | -47.835% | 4.848% | -40.905% |
| Arrowhead Pharmaceuticals Inc. | -13.280% | -6.321% | -13.578% | -19.760% | -26.314% | -63.545% | -33.226% |
| Ionis Pharmaceuticals Inc. | -1.660% | 0.491% | -4.465% | 14.510% | -5.824% | 29.392% | -23.741% |
| PTC Therapeutics Inc. | -3.850% | -4.459% | 3.448% | -17.582% | 19.048% | -18.033% | -21.977% |
| Opko Health Inc. | -2.660% | -0.585% | 20.128% | -12.854% | 2.368% | -55.116% | -11.765% |
| Ultragenyx Pharmaceutical Inc. | -3.690% | -3.689% | 21.569% | 41.714% | 14.286% | -41.647% | 6.495% |
| Ligand Pharmaceuticals | 0.540% | -0.538% | -4.639% | 50.407% | 42.308% | -20.259% | 11.634% |
| Catalent Inc. | 0.860% | 2.193% | 0.751% | 18.385% | 33.471% | -53.790% | 14.826% |
| Blueprint Medicines Corp | 1.240% | 0.048% | -5.758% | 78.376% | 1.188% | 1.335% | 22.243% |
| Amicus Therapeutics Inc. | - | 1.961% | 12.432% | -12.605% | -21.212% | 6.122% | 22.454% |
| Agios Pharmaceuticals Inc. | -1.970% | -1.456% | 0.495% | 56.154% | 97.087% | 3.863% | 22.993% |
| Neurocrine Bioscience | -3.090% | -0.629% | -21.169% | 8.538% | -7.293% | 37.085% | 24.915% |
| Exelixis Inc. | -1.320% | 0.732% | 5.739% | 11.058% | 6.947% | 40.667% | 33.425% |
| Repligen Corp. | -4.800% | -1.609% | -13.360% | -21.033% | -23.389% | -47.868% | 55.844% |
| Alnylam Pharmace. | -0.040% | -9.541% | -8.270% | 22.849% | 29.096% | 37.526% | 206.259% |
| Halozyme Therapeutics Inc. | 0.220% | -3.276% | 13.196% | 41.667% | 65.731% | 57.939% | 295.851% |